Further, we applied the assay on the sample LuCa011, which lacked the most common NSCLC-associated mutations, yet carried several rare alterations, such as a loss-of-function mutation in SMARCA4. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.